English label_2 (Q9935): Difference between revisions

From EU Knowledge Graph
Jump to navigation Jump to search
(‎Changed an Item)
(‎Removed claims)
Property / EU contribution
7,500,000.0 Czech koruna
Amount7,500,000.0 Czech koruna
UnitCzech koruna
 
Property / EU contribution: 7,500,000.0 Czech koruna / rank
Normal rank
 
Property / EU contribution
300,000.0 Euro
Amount300,000.0 Euro
UnitEuro
 
Property / EU contribution: 300,000.0 Euro / rank
Preferred rank
 
Property / EU contribution: 300,000.0 Euro / qualifier
exchange rate to Euro: 0.04 Euro
Amount0.04 Euro
UnitEuro
 
Property / EU contribution: 300,000.0 Euro / qualifier
point in time: 1 October 2020
Timestamp+2020-10-01T00:00:00Z
Timezone+00:00
CalendarGregorian
Precision1 day
Before0
After0
 
Property / budget
30,000,000.0 Czech koruna
Amount30,000,000.0 Czech koruna
UnitCzech koruna
 
Property / budget: 30,000,000.0 Czech koruna / rank
Normal rank
 
Property / budget
1,200,000.0 Euro
Amount1,200,000.0 Euro
UnitEuro
 
Property / budget: 1,200,000.0 Euro / rank
Preferred rank
 
Property / budget: 1,200,000.0 Euro / qualifier
exchange rate to Euro: 0.04 Euro
Amount0.04 Euro
UnitEuro
 
Property / budget: 1,200,000.0 Euro / qualifier
point in time: 1 October 2020
Timestamp+2020-10-01T00:00:00Z
Timezone+00:00
CalendarGregorian
Precision1 day
Before0
After0
 

Revision as of 16:22, 11 February 2020

Project in Czech Republic financed by DG Regio
Language Label Description Also known as
English
English label_2
Project in Czech Republic financed by DG Regio

    Statements

    0 references
    25 percent
    0 references
    19 November 2015
    0 references
    23 August 2018
    0 references
    1 October 2018
    0 references
    Bioveta, a.s.
    0 references
    0 references

    49°18'9.65"N, 17°4'54.52"E
    0 references

    49°17'53.88"N, 17°6'21.31"E
    0 references
    68323
    0 references
    Předmětem projektu je inovace procesu výroby a kultivace vakcín proti leptospiróze a borelióze založená na pomnožení spirochet fermentační kultivací v průmyslovém bioreaktoru. Inovace procesu bude realizována formou zavedení nové technologie výroby antigenů. Inovace se týká celé řady přípravků (např. Biocan L, Biocan Novel L4, B BioBos L, BioBos L6, Biofel B, Biocan B, Borrelym). V rámci projektu bude pořízena technologie pro nový způsob výroby, a to bioreaktory, formulační kotel a ultrafiltr. a. (Czech)
    0 references

    Identifiers

    CZ.01.1.02/0.0/0.0/15_014/0004382
    0 references